L. Redaelli

Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia

Endothelial dysfunction: molecular mechanisms and clinical implications

Effect of treatment with pravastatin or ezetimibe on endothelial function in patients with moderate hypercholesterolemia

Post-prandial endothelial dysfunction in hypertriglyceridemic subjects: Molecular mechanisms and gene expression studies